X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (106) 106
humans (105) 105
female (63) 63
middle aged (61) 61
male (60) 60
aged (54) 54
venous thrombosis (53) 53
abridged index medicus (50) 50
hematology (47) 47
medicine, general & internal (41) 41
adult (40) 40
thromboembolism (39) 39
thrombosis (34) 34
peripheral vascular disease (33) 33
anticoagulants (32) 32
rivaroxaban (32) 32
recurrence (30) 30
venous thromboembolism (30) 30
risk factors (27) 27
aged, 80 and over (26) 26
anticoagulants - therapeutic use (26) 26
follow-up studies (26) 26
hemorrhage - chemically induced (24) 24
phlebography (23) 23
pulmonary embolism (23) 23
ultrasonography (23) 23
deep-vein thrombosis (22) 22
drug therapy (22) 22
venous thrombosis - drug therapy (22) 22
prospective studies (21) 21
anticoagulants - administration & dosage (20) 20
diagnosis (19) 19
anticoagulants - adverse effects (18) 18
molecular-weight heparin (18) 18
predictive value of tests (18) 18
thrombophlebitis - diagnosis (18) 18
thrombophlebitis - diagnostic imaging (16) 16
treatment outcome (16) 16
pulmonary-embolism (15) 15
warfarin (15) 15
prevention (14) 14
vitamin k - antagonists & inhibitors (14) 14
adolescent (13) 13
risk (13) 13
veins & arteries (13) 13
health risk assessment (12) 12
pulmonary embolism - drug therapy (12) 12
research (12) 12
clinical trials (11) 11
confidence intervals (11) 11
embolisms (11) 11
enoxaparin (11) 11
medical research (11) 11
patients (11) 11
studies (11) 11
venous thromboembolism - drug therapy (11) 11
anticoagulation (10) 10
dosage and administration (10) 10
double-blind method (10) 10
heparin (10) 10
sensitivity and specificity (10) 10
ultrasonography - methods (10) 10
acute disease (9) 9
care and treatment (9) 9
enoxaparin - adverse effects (9) 9
enoxaparin - therapeutic use (9) 9
management (9) 9
rivaroxaban - therapeutic use (9) 9
surgery (9) 9
administration, oral (8) 8
deep vein thrombosis (8) 8
deep venous thrombosis (8) 8
drug administration schedule (8) 8
impedance plethysmography (8) 8
plethysmography, impedance (8) 8
unfractionated heparin (8) 8
analysis (7) 7
atrial-fibrillation (7) 7
blood clots (7) 7
cohort studies (7) 7
disease (7) 7
drug dosages (7) 7
evaluation (7) 7
health aspects (7) 7
heparin, low-molecular-weight - therapeutic use (7) 7
morpholines - therapeutic use (7) 7
prevalence (7) 7
prognosis (7) 7
reproducibility of results (7) 7
risk assessment (7) 7
thiophenes - therapeutic use (7) 7
thrombophlebitis - drug therapy (7) 7
thromboprophylaxis (7) 7
ultrasonic imaging (7) 7
venography (7) 7
warfarin - therapeutic use (7) 7
aspirin (6) 6
b-mode ultrasonography (6) 6
bleeding (6) 6
complications (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacokinetics, ISSN 0312-5963, 10/2011, Volume 50, Issue 10, pp. 675 - 686
Background and Objective: Rivaroxaban is an oral, direct Factor Xa inhibitor, which is at an advanced stage of clinical development for prevention and... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Dose-prediction | Rivaroxaban | Pharmacodynamic-modelling | Atrial-fibrillation | Deep-vein-thrombosis | Population- pharmacokinetics | Factor-Xa-inhibitors | Antithrombotics | Pharmacology | Pharmacokinetic-pharmacodynamic-relationships | Pharmacokinetic-modelling | ENOXAPARIN | IN-VITRO | FACTOR-XA INHIBITOR | BAY-59-7939 | MANAGEMENT | VENOUS THROMBOEMBOLISM | METABOLISM | ARTHROPLASTY | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | THROMBOPROPHYLAXIS | Body Weight | Age Factors | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Humans | Middle Aged | Venous Thrombosis - blood | Male | Thiophenes - administration & dosage | Morpholines - blood | Thiophenes - blood | Young Adult | Computer Simulation | Aged, 80 and over | Adult | Female | Acute Disease | Stroke - prevention & control | Venous Thrombosis - drug therapy | Administration, Oral | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Anticoagulants - blood | Atrial Fibrillation - blood | Stroke - blood | Thiophenes - pharmacokinetics | Models, Biological | Anticoagulants - pharmacology | Adolescent | Aged | Anticoagulants - pharmacokinetics | Morpholines - pharmacokinetics | Index Medicus
Journal Article
Journal Article
Annals of internal medicine, ISSN 0003-4819, 2004, Volume 140, Issue 11, pp. 867 - 873
Journal Article
Thrombosis and haemostasis, ISSN 0340-6245, 2012, Volume 107, Issue 2, pp. 225 - 231
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2004, Volume 43, Issue 12, pp. 2183 - 2190
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 12/2015, Volume 114, Issue 6, pp. 1136 - 1143
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 26, pp. 2526 - 2527
Journal Article
by Büller, Harry R and Prins, Martin H and Lensin, Anthonie W. A and Decousus, Hervé and Jacobson, Barry F and Minar, Erich and Chlumsky, Jaromir and Verhamme, Peter and Wells, Phil and Agnelli, Giancarlo and Cohen, Alexander and Berkowitz, Scott D and Bounameaux, Henri and Davidson, Bruce L and Misselwitz, Frank and Gallus, Alex S and Raskob, Gary E and Schellong, Sebastian and Segers, Annelise and Berkowitz, Scott and Gallus, Alexander and Lensing, Anthonie W. A and Haskell, Lloyd and Raskob, Gary and Bauersachs, Rupert and van Bellen, Bonno and Boda, Zoltán and Borris, Lars and Brenner, Benjamin and Brighton, Tim and Davidson, Bruce and Decousus, Herve and Eriksson, Henry and Jacobson, Barry and Kakkar, Ajay and Kwong, Yok-Lam and Lee, Lai Heng and Meijer, Karina and van der Meer, Jan and Monreal, Manuel and Piovella, Franco and Sandset, Per Morten and Smith, Mark and Tomkowski, Witold and Wang, Yuqi and Brandjes, Dees and Mac Gillavry, Melvin and Otten, Hans-Martin and Carlsson, Anders and Laporte, Silvy and Schulman, Sam and Gent, Michael and Turpie, Alexander and Martinelli, Ida and Lensing, Anthonie W and Muhlhofer, Eva and Tewes, Miriam and Trajanovic, Mila and Muller, Karin and Kim, Calvin and Gebel, Martin and Benson, Alice and Pap, Akos Ferenc and Goie, Juliette and Horvat-Broecker, Anea and Spadari, Giovanni and Peters-Wulf, Cornelia and Roig, J and Baker, R and Bianchi, A and Blombery, P and Brighton, T and Campbell, P and Carroll, P and Geraghty, R and Chong, B and Ramanathan, S and Archis, C and Coughlin, P and Salem, H and Crispin, P and Dean, M and Soni, R and Denaro, C and Kubler, P and Coghlan, D and Gallus, A and Gan, T. Eng and Tran, H and Coleman, C and Jackson, D and Khalafallah, A and Leahy, M and Leyden, M and Leyden, D and Sturtz, C and McCann, A and Gibbs, H and McRae, S and Richards, B and ... and The EINSTEIN–PE Investigators and EINSTEIN-PE Investigators and EINSTEIN–PE Investigators
The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 14, pp. 1287 - 1297
Journal Article
Journal of Medical Economics, ISSN 1369-6998, 06/2018, Volume 21, Issue 6, pp. 587 - 594
AIMSThe EINSTEIN-Extension trial (EINSTEIN-EXT) found that continued treatment with rivaroxaban for an additional 6 or 12 months (vs placebo) after 6-12 months... 
Anticoagulants | cost comparison model | rivaroxaban | economic analysis | venous thromboembolism | extended treatment | Index Medicus
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 12, p. 1178
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2006, Volume 355, Issue 17, pp. 1780 - 1789
Journal Article